Free Trial

McKesson (MCK) Stock Forecast & Price Target

McKesson logo
$788.38 +2.38 (+0.30%)
Closing price 03:59 PM Eastern
Extended Trading
$790.46 +2.08 (+0.26%)
As of 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

McKesson - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
0
Hold
3
Buy
14

Based on 17 Wall Street analysts who have issued ratings for McKesson in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 3 have given a hold rating, 13 have given a buy rating, and 1 has given a strong buy rating for MCK.

Consensus Price Target

$834.54
5.85% Upside
According to the 17 analysts' twelve-month price targets for McKesson, the average price target is $834.54. The highest price target for MCK is $900.00, while the lowest price target for MCK is $688.00. The average price target represents a forecasted upside of 5.85% from the current price of $788.38.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for MCK and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for McKesson and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MCK Analyst Ratings Over Time

TypeCurrent Forecast
10/20/24 to 10/20/25
1 Month Ago
9/20/24 to 9/20/25
3 Months Ago
7/22/24 to 7/22/25
1 Year Ago
10/21/23 to 10/20/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
9 Buy rating(s)
10 Buy rating(s)
12 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
4 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$834.54$725.10$710.17$610.86
Forecasted Upside5.85% Upside3.87% Upside0.03% Upside19.96% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

MCK Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MCK Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

McKesson Stock vs. The Competition

TypeMcKessonMedical CompaniesS&P 500
Consensus Rating Score
2.88
2.33
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside5.68% Upside1,349.20% Upside12.77% Upside
News Sentiment Rating
Positive News

See Recent MCK News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/13/2025Jefferies Financial Group
2 of 5 stars
Brian Tanquilut
Brian Tanquilut
Not Rated
Boost TargetBuy$820.00 ➝ $900.00+17.07%
10/8/2025Weiss Ratings
0 of 5 stars
 Reiterated RatingBuy (B)
9/26/2025JPMorgan Chase & Co.
2 of 5 stars
Lisa Gill
Lisa Gill
Not Rated
Boost TargetOverweight$821.00 ➝ $853.00+15.64%
9/24/2025Evercore ISI
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$800.00 ➝ $825.00+8.10%
9/24/2025Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuy
9/24/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$820.00 ➝ $860.00+16.30%
9/24/2025TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$830.00 ➝ $864.00+13.63%
9/24/2025Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$750.00 ➝ $770.00+1.16%
9/24/2025Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$810.00 ➝ $857.00+15.89%
9/24/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$820.00 ➝ $860.00+16.30%
9/24/2025Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$785.00 ➝ $850.00+14.95%
9/24/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetEqual Weight$772.00 ➝ $816.00+10.35%
9/24/2025Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$775.00 ➝ $856.00+15.76%
9/24/2025Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$800.00 ➝ $850.00+14.95%
4/4/2025Cfra Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeModerate BuyHold
11/7/2024Baird R W
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
11/7/2024Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeNeutralOutperform$531.00 ➝ $688.00+25.25%
8/8/2024Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOverweight$596.00 ➝ $616.00+12.78%
6/24/2024Argus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$570.00 ➝ $670.00+11.10%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 05:12 PM ET.


Should I Buy McKesson Stock? MCK Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 17, 2025. Please send any questions or comments about these McKesson pros and cons to contact@marketbeat.com.

McKesson
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in McKesson Co.:

  • The current stock price is around $705, which reflects a strong market capitalization of approximately $98.43 billion, indicating a solid position in the healthcare sector.
  • McKesson Co. recently reported a quarterly revenue of $97.83 billion, surpassing analysts' expectations, showcasing its robust growth and operational efficiency.
  • The company has increased its quarterly dividend to $0.82, representing a positive change from the previous dividend, which may attract income-focused investors.
  • With a P/E ratio of 31.55, McKesson Co. is positioned for potential growth, as this ratio indicates how much investors are willing to pay for each dollar of earnings, suggesting confidence in future earnings.
  • Recent insider trading activity shows that executives are actively managing their positions, which can indicate confidence in the company's future performance.

McKesson
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in McKesson Co. for these reasons:

  • The company reported earnings per share of $8.26, which missed the consensus estimate, indicating potential challenges in meeting market expectations.
  • McKesson Co. has a negative return on equity of 196.66%, suggesting that the company is not generating profit from its equity, which could be a red flag for investors.
  • Insider sales have been significant, with over 24,000 shares sold recently, which may raise concerns about the executives' confidence in the company's future performance.
  • The stock has experienced fluctuations, with a 1-year high of $792.34 and a low of $492.39, indicating volatility that may deter risk-averse investors.
  • The beta of 0.52 suggests that the stock is less volatile than the market, which may not appeal to investors seeking high-growth opportunities.

MCK Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for McKesson is $834.54, with a high forecast of $900.00 and a low forecast of $688.00.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last twelve months. There are currently 3 hold ratings, 13 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" MCK shares.

According to analysts, McKesson's stock has a predicted upside of 5.85% based on their 12-month stock forecasts.

Analysts like McKesson more than other "medical" companies. The consensus rating for McKesson is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how MCK compares to other companies.


This page (NYSE:MCK) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners